{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:14Z","timestamp":1707524654921},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,16]]},"DOI":"10.7759\/cureus.28058","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T13:02:25Z","timestamp":1660654945000},"source":"Crossref","is-referenced-by-count":0,"title":["How to Treat Algodystrophy and Rheumatic Comorbidity in Myelofibrosis: Three Case Reports"],"prefix":"10.7759","author":[{"given":"Olga","family":"Magazzino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Magnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2018.01.004","article-title":"Signs and symptoms in 1,043 patients with complex regional pain syndrome","volume":"19","author":"Ott S","year":"2018","unstructured":"Ott S, Maih\u00f6fner C. Signs and symptoms in 1,043 patients with complex regional pain syndrome. J Pain. 2018, 19:599-611. 10.1016\/j.jpain.2018.01.004","journal-title":"J Pain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00279-4","article-title":"Complex regional pain syndrome: a comprehensive review","volume":"10","author":"Taylor SS","year":"2021","unstructured":"Taylor SS, Noor N, Urits I, et al.. Complex regional pain syndrome: a comprehensive review. Pain Ther. 2021, 10:875-92. 10.1007\/s40122-021-00279-4","journal-title":"Pain Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12465","article-title":"Inflammation in cold complex regional pain syndrome","volume":"59","author":"Dirckx M","year":"2015","unstructured":"Dirckx M, Stronks DL, van Bodegraven-Hof EA, Wesseldijk F, Groeneweg JG, Huygen FJ. Inflammation in cold complex regional pain syndrome. Acta Anaesthesiol Scand. 2015, 59:733-9. 10.1111\/aas.12465","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150088","article-title":"Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?","volume":"129","author":"Bianchi E","year":"2015","unstructured":"Bianchi E, Taurone S, Bardella L, et al.. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?. Clin Sci (Lond). 2015, 129:711-20. 10.1042\/CS20150088","journal-title":"Clin Sci (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7697214","article-title":"Molecular aspects of regional pain syndrome","volume":"2020","author":"Baronio M","year":"2020","unstructured":"Baronio M, Sadia H, Paolacci S, et al.. Molecular aspects of regional pain syndrome. Pain Res Manag. 2020, 2020:7697214. 10.1155\/2020\/7697214","journal-title":"Pain Res Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hcl.2015.08.003","article-title":"New concepts in complex regional pain syndrome","volume":"32","author":"Tajerian M","year":"2016","unstructured":"Tajerian M, Clark JD. New concepts in complex regional pain syndrome. Hand Clin. 2016, 32:41-9. 10.1016\/j.hcl.2015.08.003","journal-title":"Hand Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.007","article-title":"Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome","volume":"155","author":"Li WW","year":"2014","unstructured":"Li WW, Guo TZ, Shi X, et al.. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain. 2014, 155:2377-89. 10.1016\/j.pain.2014.09.007","journal-title":"Pain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.03.009","article-title":"Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen","volume":"143","author":"Kohr D","year":"2009","unstructured":"Kohr D, Tschernatsch M, Schmitz K, et al.. Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain. 2009, 143:246-51. 10.1016\/j.pain.2009.03.009","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211014020","article-title":"Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study","volume":"13","author":"Varenna M","year":"2021","unstructured":"Varenna M, Braga V, Gatti D, et al.. Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. Ther Adv Musculoskelet Dis. 2021, 13:1759720X211014020. 10.1177\/1759720X211014020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes312","article-title":"Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Varenna M","year":"2013","unstructured":"Varenna M, Adami S, Rossini M, et al.. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology (Oxford). 2013, 52:534-42. 10.1093\/rheumatology\/kes312","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.03.009","article-title":"Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo","volume":"84","author":"Chevreau M","year":"2017","unstructured":"Chevreau M, Romand X, Gaudin P, Juvin R, Baillet A. Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: A systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017, 84:393-9. 10.1016\/j.jbspin.2017.03.009","journal-title":"Joint Bone Spine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683401","article-title":"Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms","volume":"12","author":"Fisher DA","year":"2021","unstructured":"Fisher DA, Fowles JS, Zhou A, Oh ST. Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms. Front Immunol. 2021, 12:683401. 10.3389\/fimmu.2021.683401","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek S","year":"2010","unstructured":"Verstovsek S, Kantarjian H, Mesa RA, et al.. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med. 2010, 363:1117-27. 10.1056\/NEJMoa1002028","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0379-y","article-title":"Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF\u03baB signaling","volume":"33","author":"Fisher DA","year":"2019","unstructured":"Fisher DA, Miner CA, Engle EK, et al.. Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF\u03baB signaling. Leukemia. 2019, 33:1978-95. 10.1038\/s41375-019-0379-y","journal-title":"Leukemia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1967138","article-title":"Bone marrow morphological features and therapy in patients with Philadelphia-negative neoplasms","volume":"14","author":"Pich A","year":"2021","unstructured":"Pich A, Beggiato E, Godio L, Riera L, Francia di Celle P, Lanzarone G, Benevolo G. Bone marrow morphological features and therapy in patients with Philadelphia-negative neoplasms. Expert Rev Hematol. 2021, 14:841-50. 10.1080\/17474086.2021.1967138","journal-title":"Expert Rev Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1747-0","article-title":"Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia","volume":"32","author":"Ayvaz OC","year":"2012","unstructured":"Ayvaz OC, Yavasoglu I, Kadikoylu G, Bozkurt G, Bolaman Z. Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia. Rheumatol Int. 2012, 32:269-71. 10.1007\/s00296-010-1747-0","journal-title":"Rheumatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1983-y","article-title":"Recurrence of severe low back pain due to myeloproliferative disorder in a patient affected by seronegative spondyloarthropathy","volume":"32","author":"Caramaschi P","year":"2012","unstructured":"Caramaschi P, Zam\u00f2 A, Carletto A, Biasi D. Recurrence of severe low back pain due to myeloproliferative disorder in a patient affected by seronegative spondyloarthropathy. Rheumatol Int. 2012, 32:1845-6. 10.1007\/s00296-011-1983-y","journal-title":"Rheumatol Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2298\/sarh1602081z","article-title":"A case of essential thrombocythemia and ankylosing spondylitis treated with a combination of anagrelide, disease-modifying antirheumatic drugs, and etanercept","volume":"144","author":"Zeremski V","year":"2016","unstructured":"Zeremski V, Savi\u0107 A, Ili\u0107 T, Milosevi\u0107 I, Maksimovi\u0107 M, Vuckovi\u0107 B. A case of essential thrombocythemia and ankylosing spondylitis treated with a combination of anagrelide, disease-modifying antirheumatic drugs, and etanercept. Srp Arh Celok Lek. 2016, 144:81-4. 10.2298\/sarh1602081z","journal-title":"Srp Arh Celok Lek"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.344.15281","article-title":"An elusive case of digital ischemia in a patient with Rheumatoid Arthritis","volume":"34","author":"Azam W","year":"2018","unstructured":"Azam W, Erum U, Muhammad AJ. An elusive case of digital ischemia in a patient with Rheumatoid Arthritis. Pak J Med Sci. 2018, 34:1024-6. 10.12669\/pjms.344.15281","journal-title":"Pak J Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/869743","article-title":"Myelofibrosis-related arthritis successfully treated with hydroxyurea","volume":"2014","author":"Guillot X","year":"2014","unstructured":"Guillot X, Moldovan M, Vidon C, Wendling D. Myelofibrosis-related arthritis successfully treated with hydroxyurea. Case Rep Rheumatol. 2014, 2014:869743. 10.1155\/2014\/869743","journal-title":"Case Rep Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97844-how-to-treat-algodystrophy-and-rheumatic-comorbidity-in-myelofibrosis-three-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:37Z","timestamp":1707507517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97844-how-to-treat-algodystrophy-and-rheumatic-comorbidity-in-myelofibrosis-three-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.28058","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}